Genetic Signatures

Genetic Signatures Stock-Based Compensation

The Stock-Based Compensation (SBC) of Genetic Signatures (GSS.AX) as of Oct 10, 2026 is 1.97 M AUD. In the previous year, Stock-Based Compensation (SBC) was 1.92 M AUD — a change of 3.03% (higher).

Stock-Based Compensation

1.97 MAUD

YoY

3.03%

Last updated:

Stock-Based Compensation (SBC) of Genetic Signatures is 2023 1.97 M AUD. Stock-Based Compensation (SBC) of Genetic Signatures was 2022 1.92 M AUD. It decreases by 3.03% higher compared to the previous year.

The Genetic Signatures Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2016
590,339.00 AUD
Jan 1, 2017
263,850.00 AUD
Jan 1, 2018
192,990.00 AUD
Jan 1, 2019
425,000.00 AUD
Jan 1, 2020
572,000.00 AUD
Jan 1, 2021
1.48 M AUD
Jan 1, 2022
1.92 M AUD
Jan 1, 2023
1.97 M AUD
The Genetic Signatures Stock-Based Compensation history
YEARStock-Based CompensationYoY
1.97 MAUD+3.03%
1.92 MAUD+29.13%
1.48 MAUD+159.27%
572,000.00AUD+34.59%
425,000.00AUD+120.22%
192,990.00AUD-26.86%
263,850.00AUD-55.31%
590,339.00AUD+290.83%
151,046.00AUD—
Access this data via the Eulerpool API
Get Free API Key

Genetic Signatures Stock analysis

What does Genetic Signatures do? Genetic Signatures is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genetic Signatures stock

Stock-Based Compensation (SBC) of Genetic Signatures is 1.97 M AUD in 2023.

Stock-Based Compensation (SBC) of Genetic Signatures changed from 1.92 M AUD to 1.97 M AUD, representing a 3.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Genetic Signatures since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Genetic Signatures historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genetic Signatures

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genetic Signatures